Recombinant Lysophospholipase II (LYPLA2)

Prokaryotic expression

Product No.

RPD850Hu01

Organism Species

Homo sapiens (Human).

Source

Prokaryotic expression

Host

E.coli

Endotoxin Level

<1.0EU per 1µg (determined by the LAL method)

Subcellular Location

Cytoplasm, Extracellular matrix

Predicted Molecular Mass

24.5kDa

Accurate Molecular Mass

24kDa(Analysis of differences refer to the manual)

Residues & Tags

Met1~Thr196 with N-terminal His Tag

Buffer Formulation

100mMNaHCO3, 500mMNaCl, pH8.3, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.

Traits

Freeze-dried powder

Purity

> 95%

Isoelectric Point

6.4

Applications

Positive Control; Immunogen; SDS-PAGE; WB.

If bio-activity of the protein is needed, please check active protein.

UOM

10µg 50µg 200µg 1mg 5mg

SEQUENCE

 

 

 

USAGE

Reconstitute in 100mM NaHCO₃, 500mM NaCl (pH8.3) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

 

Catalog No.	Related products for research use of Homo sapiens (Human) Organism species	Applications (RESEARCH USE ONLY!)
RPD850Hu01	Recombinant Lysophospholipase II (LYPLA2)	Positive Control; Immunogen; SDS-PAGE; WB.
PAD850Hu01	Polyclonal Antibody to Lysophospholipase II (LYPLA2)	WB; IHC; ICC; IP.